SpringWorks Therapeutics, Inc.SpringWorks Therapeutics, Inc.SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.

No trades
See on Supercharts

Price target

67.330.000.00%
The 9 analysts offering 1 year price forecasts for SWTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to SWTX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SWTX EPS for the last quarter is −0.72 USD despite the estimation of −0.75 USD. In the next quarter EPS is expected to reach −0.65 USD. Track more of SpringWorks Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter SpringWorks Therapeutics, Inc. revenue is expected to reach ‪56.34 M‬ USD. Check out SpringWorks Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SWTX price target is 67.33 USD with a max estimate of 80.00 USD and a min estimate of 58.00 USD. Check if this forecast comes true in a year, meanwhile watch SpringWorks Therapeutics, Inc. stock price chart and keep track of the current situation with SWTX news and stock market news.
We've gathered opinions of 9 analysts rating SWTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.